AR19, a manipulation-resistant formulation of amphetamine sulfate, was created to address the problem of non-oral use of stimulant medications (eg, smoking, injecting). In this video, Dr Faraone highlights the findings and implications of a recent randomized controlled trial of AR19 in adult ADHD.
Insights August 24, 2021
AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adult ADHD
Vol 86 • 2025 • Number 1
Read the Current Issue
Brief Report
Sex Differences in PTSD among US Military Veterans
Commentary
The Opioid Industry's Legacy: A Generation of Prescribed Suffering
Clinical and Practical Psychopharmacology
Cannabis Use in Pregnancy and ASD or ADHD in Offspring
Commentary
Evolving Care and Research Priorities in ADHD
Original Research
Treatments and Treatment Predictors in Patients With SUDs and ADHD
Systematic Review